CEA immunohistochemistry: what the result can tell you

CEA stands for carcinoembryonic antigen. A positive stain can support a pathologist's impression about how cells are differentiating, but it does not identify a cancer type or its site of origin on its own.

The report may describe whether staining is present, which cells show it, and where the colour appears within or around those cells. The distribution matters because different tissue types can share CEA expression. Pathologists combine this pattern with the cells' appearance, the biopsy location, and a panel of other stains.

A tissue CEA stain is different from a CEA blood test. The stain examines protein within a specimen under a microscope; the blood test measures a circulating marker and answers a different clinical question. Neither result should be interpreted in isolation.

Review the final diagnosis section of the pathology report before focusing on a single stain. Ask whether CEA was one part of a broader panel, what alternatives the panel was designed to assess, and whether the sample contained enough representative tissue.

If the wording is uncertain or the result could alter treatment, the treating team may request additional stains, molecular testing, more tissue, or review by a pathologist with relevant specialist experience. The useful next step depends on the entire specimen and clinical picture.

The stain result itself is not a medical emergency. Contact the clinic promptly if you cannot access the final pathology interpretation, if you have been given conflicting explanations, or if a planned treatment decision is approaching without a clear diagnosis.

After a biopsy, seek urgent medical assessment for heavy bleeding, increasing swelling, difficulty breathing, fainting, or rapidly worsening pain. Fever, spreading redness, warmth, drainage, or worsening tenderness at the biopsy site also warrants timely clinical advice because these can indicate a procedure-related problem.

You might ask: What did the staining pattern contribute to the final diagnosis? Which other markers were assessed? Does the result narrow the likely tissue of origin? Is the conclusion definite, or is further testing or specialist pathology review needed?